acute opioid-induced harms.
We propose that 4 opioid-related "emergencies" meet the criteria for a PHE. First, opioid-related deaths are rising at unprecedented rates, with more than 116 Americans fatally overdosing per day in 2016. 3 Second, transmissions of HIV and hepatitis C have recently spiked. Third, the number of children in foster care is rising after a longstanding decline. Finally, the provision of evidence-based opioid use disorder treatment or medication-assisted therapy (MAT) that could help avert future growth in these outcomes remains scant, particularly in rural areas of the United States. Public health emergency powers and money in the public health emergency fund alone are insufficient, and additional steps and appropriations are required.
Opioid-Related Overdoses
Although drug-related overdoses increased at a rate of 9% per year from 1979 to 2015, 4 this death rateattributable increasingly to heroin and synthetic opioids-increased by 21.4% from 2015 to 2016 (Figure) . 3 The most direct means of averting deaths from overdose is to expand access to naloxone hydrochloride, the opioid overdose reversal drug with high effectiveness when administered quickly and appropriately. Some states and communities have expanded access to naloxone by equipping first responders, family, and friends with the drug. Nevertheless, the dose of naloxone required to reverse overdoses of synthetic opioids is at least 5 times greater than that typically available, so product and distribution restructuring is required. National spending on naloxone has grown from $10.5 million in 2013 to $108.6 million in the second quarter of 2017 (data purchased by R.G.F. from Iqvia from all distribution channels and tabulated by R.L.H. and R.G.F.). 1 Growth in the share of overdoses involving potent synthetic opioids and the population with opioid use disorders (around 2.5 million individuals) mean that demand for naloxone is increasing. 7 However, federal funding lines devoted toward naloxone have remained steady for 2017 and 2018. 7 Conservatively estimating that, on average, 14.55 naloxone doses dispensed result in 1 life saved after an opioid overdose, millions of additional doses are needed at costs that overwhelm state resources. 8 Congressional appropriation of money into the public health emergency fund or otherwise could immediately facilitate purchases of naloxone and training in its administration.
Transmission of Infectious Diseases
Rising opioid use, particularly with injected illicit sources such as heroin, has been linked to outbreaks of HIV and hepatitis C. Nationwide, new hepatitis C infections have risen 167% since 2010 after decreasing by 87% from 1992 to 2009 (Figure) . 6 Using clean syringes for every injection, including at supervised syringe exchange programs that facilitate substance use treatment and access to naloxone, is an evidence-based approach to reducing transmission of infectious diseases. The federal government could promote the use of clean syringes via rapid appropriations. Providing the 700 000 persons with heroin use disorders who are potentially using it via injection 7 with needle exchange access at a price of about $20 per person would cost $14 million. Alongside funding, the Department of Justice could indicate that it will not prosecute Controlled Substances Act crimes of being in possession of illicit drugs at needle exchange programs.
Foster Care
After declining by almost 30% from 1999 to 2012, the number of children in foster care rose nationally by 7% between 2012 and 2016 ( Figure) , 5 largely owing to parents' opioid-related overdoses. The states with the 5 highest rates of additions to the foster care system also have opioid mortality rates well above the national average. 3, 5 Immediate steps to address this influx of orphans include reversal of opioid-related overdoses using naloxone and increasing MAT provision. Money from the public health emergency fund or federal supplemental grants could also assist depleted state foster care systems. There were approximately 40 000 new foster care cases in 2016 compared with 2012, and maintaining a foster child costs about $19 000 per year. 9 Thus, the acute effect of the opioid epidemic on the foster care system is roughly $760 million.
VIEWPOINT

Rural MAT
Finally, MAT has a strong evidence base and holds the potential to avert opioid-related overdoses, parental deaths that orphan their children, and infectious disease transmissions. Although addiction is a chronic disease and treatment is a long-term prospect, certain acute steps would jump-start treatment and would address severe rural shortages. Roughly one-fourth of those with opioid use disorders receive treatment. Compared with urban counties, significantly higher percentages of rural counties lack any substance abuse treatment facility (55%), opioid treatment program (>90%), or buprenorphine provider (72%). 7 The costs of MAT impose additional barriers, especially in states that chose not to expand Medicaid. In addition to many of the strategies recommended to increase the availability and use of naloxone, federal actions to address severe shortages of rural MAT providers under the PHE include deploying federally funded public health personnel to provide MAT, and allowing telemedicine clinicians to prescribe buprenorphine hydrochloride without performing an in-person examination. If President Trump, concurrently with the PHE, declared a national emergency under the Robert T. Stafford Disaster Relief and Emergency Assistance Act or the National Emergencies Act, the Department of Health and Human Services could further facilitate robust MAT by relaxing the Drug Addiction Treatment Act of 2000 waiver requirements for buprenorphine prescribing, and waiving the consent requirements of 42 CFR Part 2 (Confidentiality of Substance Use Disorder Patient Records) when disclosure of certain substance use treatment program records pertains to coordinating other addiction-related treatment.
Conclusions
The current administration appropriately drew national attention to the opioid epidemic by declaring it a PHE, but symbolism alone will not triage acute opioid-related harms experienced daily. The primary shortcoming of this PHE is the virtual absence of funds available to address the epidemic's emergency components. The magnitude of current appropriations is small relative to the epidemic's costs. Although many longer-term actions-including prescriber education, pain therapy alternatives, heightened oversight of illicit opioids, and robust addiction therapy-are needed, emergency steps can and should be taken to address the opioid-related imminent harms. Role of the Funder/Sponsor: The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. 
